Please login to the form below

Not currently logged in
Email:
Password:

Empliciti

This page shows the latest Empliciti news and features for those working in and with pharma, biotech and healthcare.

Sanofi's Darzalex rival scores in myeloma trial

Sanofi's Darzalex rival scores in myeloma trial

Another rival is Bristol-Myers Squibb and AbbVie’s Empliciti (elotuzumab), which targets SLAMF7 rather than CD38 which was approved for the relapsed/refractory patient population in 2015 in combination with

Latest news

More from news
Approximately 7 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics